NEW YORK (GenomeWeb News) – HairDx today said that Biodue of Florence, Italy, has inked a deal to be the firm's exclusive distributor of its tests in Italy.

HairDx sells genetic tests that are designed to predict a patient's likelihood of developing Androgenetic Alopecia, the most common type of hair loss. Biodue will off the tests to customers through Italian dermatologists.

Financial and other terms of the partnership were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.